SCHEMBL14655002

SCHEMBL14655002

CCOP(C)(=O)N1CCC([N+](C)(C)C)CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15443876 0.79 GNAI3 (0.33) TSHR
SCHEMBL15443877 0.76 L3MBTL3 (0.33) TSHR
SCHEMBL14654986 0.75 MAPK1 (0.41)
SCHEMBL15443892 0.75 TSHR (0.30) TSHR
SCHEMBL15443900 0.75 ACHE (0.33) TSHR
SCHEMBL14655015 0.73 MAPK1 (0.43)
SCHEMBL15443801 0.72 TSHR (0.37) TSHR
SCHEMBL15443901 0.71 CHRM1 (0.35)
SCHEMBL19981483 0.71 EBP (0.35)
SCHEMBL15443760 0.71 MEN1 (0.41) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788487-B1 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-04-04 EP disclosed
EP-2788488-B1 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-03-21 EP disclosed
WO-2013012752-A2 METHODS AND COMPOSITIONS FOR MANIPULATING TRANSLATION OF PROTEIN ISOFORMS FROM ALTERNATIVE INITIATION START SITES SAREPTA THERAPEUTICS, INC. (US) 2013-01-24 WO disclosed